Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.

Eisman JA, Cortet B, Boolell M, Ionescu-Ittu R, Vekeman F, Heroux J, Thomasius F

Open source

DOI
10.1007/s00198-022-06627-0
Published
2023 May
Container
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00198-022-06627-0,
  title = {Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.},
  author = {Eisman JA and Cortet B and Boolell M and Ionescu-Ittu R and Vekeman F and Heroux J and Thomasius F},
  year = {2023},
  journal = {Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA},
  doi = {10.1007/s00198-022-06627-0},
  url = {https://doi.org/10.1007/s00198-022-06627-0}
}

RIS

TY  - JOUR
TI  - Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.
AU  - Eisman JA
AU  - Cortet B
AU  - Boolell M
AU  - Ionescu-Ittu R
AU  - Vekeman F
AU  - Heroux J
AU  - Thomasius F
PY  - 2023
JO  - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
DO  - 10.1007/s00198-022-06627-0
UR  - https://doi.org/10.1007/s00198-022-06627-0
ER  - 

APA

JA, E., B, C., M, B., R, I., F, V., J, H., & F, T. (2023). Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. https://doi.org/10.1007/s00198-022-06627-0

Source records